Work

Early clinical activity and pharmacodynamic effects of duvelisib, a PI3K-δ,γ inhibitor, in patients with treatment-naïve CLL.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.7074

Authors: Manish R. Patel, Susan Mary O'Brien, Kerrie Faia, Kerry White, Mark Douglas, Kerstin Allen, Jeffrey Lorne Kutok, Jennifer Sweeney, Virginia Kelly, Ian Flinn, John C. Byrd, Howard Stern

Institutions: UC Irvine Health, UC Irvine Chao Family Comprehensive Cancer Center, Infinity Pharmaceuticals (United States), Sarah Cannon, Tennessee Oncology, The Ohio State University Wexner Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2757924882

Cites:

Cited by: 11

Related to: 10